{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-121064","form_type":"8-K","ticker":"BRKR","cik":"0001109354","company_name":"BRUKER CORP","filed_at":"2024-11-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.694223+00:00","generated_at":"2026-05-30T05:09:27.580326+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Bruker Q3 revenue up 16.4% but GAAP EPS $0.27 down from $0.60; FY2024 guidance lowered","bullets":["Q3 revenue $864.4M, up 16.4% YoY; organic growth 3.1%, CER growth 15.7%.","GAAP EPS $0.27 vs $0.60 prior year; non-GAAP EPS $0.60 vs $0.74, down 18.9%.","BSI segment organic revenue grew 3.8% YoY; BEST segment organic revenue declined 3.2%.","FY2024 revenue guidance lowered to $3.34-$3.37B (organic growth 3-4%); non-GAAP EPS $2.36-$2.41.","Management cites persistent biopharma and China headwinds as reason for guidance cut."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-121064","json":"https://secwatch.observer/filing/0000950170-24-121064.json","markdown":"https://secwatch.observer/filing/0000950170-24-121064.md","text":"https://secwatch.observer/filing/0000950170-24-121064.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1109354/000095017024121064/0000950170-24-121064-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1109354/000095017024121064/brkr-20241105.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T05:09:27.580326+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}